Input variables of the threshold and cost-effectiveness analyses of IPTp-MQ compared with IPTp-SP in HIV-negative pregnant women.

All monetary values are expressed in US$ 2012IPTp = Intermittent Preventive Treatment of malaria in pregnancy; HIV = Human Immunodeficiency VirusMQ = Mefloquine; SP = Sulphadoxine-Phyrimethamine; PYAR = Person-year at risk; RR = Relative Risk.α, β are the parameters of the Beta and Gamma distributions and μ, σ are the parameters of the lognormal distribution.*Medicine for malaria venture price under negotiation and ranges given by lowest and highest Global Fund procurement prices.**The average Global Fund procurement price for SP in Sub-Saharan Africa for the year 2012.Input variables of the threshold and cost-effectiveness analyses of IPTp-MQ compared with IPTp-SP in HIV-negative pregnant women.